Critical Success Factors for Competitive Advantage in Iranian Pharmaceutical Companies: A Comprehensive MCDM Approach

Table 9

Weighted matrix and result of the computation.

	Max	Max	Max	Max	Max	Max	Max	Min	Max	Max	Max	Max	S	K	Rank
CSFs	Manufacturing strategy	Formal strategy planning	Manufacturing involvement	Supplier involvement	Product innovation	Customer support	Infrastructural organization	Cost	Quality	Delivery	Flexibility	Customer satisfaction
Optimal value	0.0533	0.0293	0.0154	0.0095	0.0061	0.0044	0.0029	0.0007	0.0009	0.0008	0.0005	0.0002	0.1239	1.000
Firm 1	0.0466	0.0261	0.0154	0.0042	0.0034	0.0044	0.0029	0.0011	0.0005	0.0006	0.0004	0.0002	0.1057	0.853	3
Firm 2	0.0333	0.0130	0.0137	0.0074	0.0061	0.0033	0.0029	0.0013	0.0008	0.0006	0.0001	0.0002	0.0826	0.667	7
Firm 3	0.0266	0.0228	0.0085	0.0084	0.0061	0.0033	0.0022	0.0016	0.0008	0.0004	0.0005	0.0002	0.0816	0.658	8
Firm 4	0.0533	0.0228	0.0085	0.0095	0.0041	0.0044	0.0022	0.0016	0.0005	0.0003	0.0004	0.0002	0.1079	0.871	2
Firm 5	0.0466	0.0261	0.0137	0.0095	0.0054	0.0028	0.0019	0.0016	0.0007	0.0007	0.0005	0.0001	0.1095	0.883	1
Firm 6	0.0466	0.0261	0.0154	0.0053	0.0027	0.0011	0.0019	0.0021	0.0005	0.0003	0.0004	0.0002	0.1026	0.828	5
Firm 7	0.0400	0.0293	0.0137	0.0074	0.0054	0.0028	0.0019	0.0016	0.0007	0.0007	0.0005	0.0002	0.1040	0.840	4
Firm 8	0.0333	0.0130	0.0102	0.0032	0.0061	0.0044	0.0022	0.0008	0.0009	0.0007	0.0004	0.0002	0.0755	0.609	9
Firm 9	0.0200	0.0163	0.0102	0.0084	0.0061	0.0039	0.0022	0.0008	0.0009	0.0007	0.0004	0.0002	0.0701	0.566	10
Firm 10	0.0400	0.0196	0.0085	0.0095	0.0054	0.0033	0.0022	0.0008	0.0009	0.0003	0.0002	0.0001	0.0908	0.733	6
Firm 11	0.0266	0.0098	0.0102	0.0053	0.0061	0.0044	0.0022	0.0008	0.0008	0.0008	0.0004	0.0002	0.0676	0.545	11